These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
217 related items for PubMed ID: 7987823
1. Kinetics of the in vivo interconversion of the carboxylate and lactone forms of irinotecan (CPT-11) and of its metabolite SN-38 in patients. Rivory LP, Chatelut E, Canal P, Mathieu-Boué A, Robert J. Cancer Res; 1994 Dec 15; 54(24):6330-3. PubMed ID: 7987823 [Abstract] [Full Text] [Related]
2. Clinical pharmacokinetics of irinotecan and its metabolites: a population analysis. Xie R, Mathijssen RH, Sparreboom A, Verweij J, Karlsson MO. J Clin Oncol; 2002 Aug 01; 20(15):3293-301. PubMed ID: 12149304 [Abstract] [Full Text] [Related]
4. Pharmacological correlation between total drug concentration and lactones of CPT-11 and SN-38 in patients treated with CPT-11. Sasaki Y, Yoshida Y, Sudoh K, Hakusui H, Fujii H, Ohtsu T, Wakita H, Igarashi T, Itoh K. Jpn J Cancer Res; 1995 Jan 01; 86(1):111-6. PubMed ID: 7737902 [Abstract] [Full Text] [Related]
6. The transformation of irinotecan (CPT-11) to its active metabolite SN-38 by human liver microsomes. Differential hydrolysis for the lactone and carboxylate forms. Haaz MC, Rivory LP, Riché C, Robert J. Naunyn Schmiedebergs Arch Pharmacol; 1997 Aug 01; 356(2):257-62. PubMed ID: 9272733 [Abstract] [Full Text] [Related]
7. 20-O-acylcamptothecin derivatives: evidence for lactone stabilization. Zhao H, Lee C, Sai P, Choe YH, Boro M, Pendri A, Guan S, Greenwald RB. J Org Chem; 2000 Jul 28; 65(15):4601-6. PubMed ID: 10959865 [Abstract] [Full Text] [Related]
10. Simultaneous determination of the lactone and carboxylate forms of irinotecan (CPT-11) and its active metabolite SN-38 by high-performance liquid chromatography: application to plasma pharmacokinetic studies in the rat. Yang X, Hu Z, Chan SY, Goh BC, Duan W, Chan E, Zhou S. J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Jul 25; 821(2):221-8. PubMed ID: 15936253 [Abstract] [Full Text] [Related]
13. Determination of irinotecan and its metabolite SN-38 in rabbit plasma and tumors using a validated method of tandem mass spectrometry coupled with liquid chromatography. Park DJ, Won JH, Cho AR, Yun HJ, Heo JH, Hwhang TH, Lee DH, Kim WM. J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jul 01; 962():147-152. PubMed ID: 24927278 [Abstract] [Full Text] [Related]
18. Plasma and cerebrospinal fluid pharmacokinetics of 9-aminocamptothecin (9-AC), irinotecan (CPT-11), and SN-38 in nonhuman primates. Blaney SM, Takimoto C, Murry DJ, Kuttesch N, McCully C, Cole DE, Godwin K, Balis FM. Cancer Chemother Pharmacol; 1998 Jul 01; 41(6):464-8. PubMed ID: 9554590 [Abstract] [Full Text] [Related]
19. Identification of a new metabolite of CPT-11 (irinotecan): pharmacological properties and activation to SN-38. Dodds HM, Haaz MC, Riou JF, Robert J, Rivory LP. J Pharmacol Exp Ther; 1998 Jul 01; 286(1):578-83. PubMed ID: 9655905 [Abstract] [Full Text] [Related]
20. Kinetics of lactone hydrolysis in antitumor drugs of camptothecin series as studied by fluorescence spectroscopy. Chourpa I, Millot JM, Sockalingum GD, Riou JF, Manfait M. Biochim Biophys Acta; 1998 Mar 02; 1379(3):353-66. PubMed ID: 9545598 [Abstract] [Full Text] [Related] Page: [Next] [New Search]